Spinal Tech

The Food and Drug Administration granted 25 spine-related device clearances in April.

The U.S. Patent and Trademark Office issued InVivo Therapeutics a Notice of Allowance for the U.S. Patent Application, "Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries."

The global spine devices market is anticipated to grow to 2022, according to newsmaker.

Vystar appointed Keith D. Osborn, MD, of Atlanta-based Resurgens Orthopaedics, to its board of directors, according to Digital Journal.

Mazor signed a commercial and investment agreement with Medtronic.

Cartiva announced that the results of a study comparing the efficacy and safety of the Cartiva Synthetic Cartilage Implant to arthrodesis for treatment of advanced-stage hallux rigidus.

Histogenics acquired the sole development and commercialization rights to NeoCart for the Japanese market from its development partner Purpose.

Here are 12 recent mergers, acquisitions and partnership agreements that took place among spine and orthopedic companies.

K2M will present its RAVINE Lateral Access System research at the SpineWeek 2106 Annual Meeting in Singapore.

Misonix will showcase its new BoneScalpel MIS at the SpineWeek 2106 Annual Meeting in Singapore.